LV12174B - FATS WITH SPECIFIC ANTI-CELLULOTIC EFFECTS - Google Patents
FATS WITH SPECIFIC ANTI-CELLULOTIC EFFECTS Download PDFInfo
- Publication number
- LV12174B LV12174B LVP-98-156A LV980156A LV12174B LV 12174 B LV12174 B LV 12174B LV 980156 A LV980156 A LV 980156A LV 12174 B LV12174 B LV 12174B
- Authority
- LV
- Latvia
- Prior art keywords
- units
- weight
- fat
- fat phase
- vitamin
- Prior art date
Links
- 230000000694 effects Effects 0.000 title description 6
- 239000003925 fat Substances 0.000 claims description 86
- 235000019197 fats Nutrition 0.000 claims description 86
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000654 additive Substances 0.000 claims description 19
- 235000012000 cholesterol Nutrition 0.000 claims description 19
- 239000003995 emulsifying agent Substances 0.000 claims description 16
- 235000019737 Animal fat Nutrition 0.000 claims description 11
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 11
- 235000019198 oils Nutrition 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 235000019160 vitamin B3 Nutrition 0.000 claims description 11
- 239000011708 vitamin B3 Substances 0.000 claims description 11
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims description 10
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims description 10
- 230000000055 hyoplipidemic effect Effects 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 235000013310 margarine Nutrition 0.000 claims description 7
- 235000013311 vegetables Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229920000881 Modified starch Polymers 0.000 claims description 6
- 235000014121 butter Nutrition 0.000 claims description 6
- 239000003264 margarine Substances 0.000 claims description 6
- 235000019426 modified starch Nutrition 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 6
- 235000019871 vegetable fat Nutrition 0.000 claims description 6
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 230000002930 anti-sclerotic effect Effects 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 239000001814 pectin Substances 0.000 claims 2
- -1 phospholipid esters Chemical class 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 229940075554 sorbate Drugs 0.000 description 8
- 239000001828 Gelatine Substances 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 238000008214 LDL Cholesterol Methods 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical class O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/015—Reducing calorie content; Reducing fat content, e.g. "halvarines"
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Edible Oils And Fats (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ963268A CZ326896A3 (cs) | 1996-11-07 | 1996-11-07 | Tuk se specifickými protisklerotickými účinky |
| PCT/CZ1997/000038 WO1998019555A1 (en) | 1996-11-07 | 1997-10-30 | Fat with specific antisclerosis effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12174A LV12174A (lv) | 1998-12-20 |
| LV12174B true LV12174B (en) | 1999-05-20 |
Family
ID=5466435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-98-156A LV12174B (en) | 1996-11-07 | 1998-07-27 | FATS WITH SPECIFIC ANTI-CELLULOTIC EFFECTS |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0918466A1 (cs) |
| CZ (1) | CZ326896A3 (cs) |
| EA (1) | EA199800624A1 (cs) |
| EE (1) | EE9800212A (cs) |
| HU (1) | HUP0001100A3 (cs) |
| LT (1) | LT4528B (cs) |
| LV (1) | LV12174B (cs) |
| PL (1) | PL327668A1 (cs) |
| SK (1) | SK93098A3 (cs) |
| WO (1) | WO1998019555A1 (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4734B (lt) | 2000-01-21 | 2000-11-27 | Alfridas Putramentas | Aliejų kompozicija |
| WO2002063976A1 (en) * | 2001-02-09 | 2002-08-22 | Unilever N.V. | Food product comprising soy protein and statins |
| CN1946302A (zh) * | 2004-04-28 | 2007-04-11 | 荷兰联合利华有限公司 | 含他汀的食用油 |
| BRPI0513939A (pt) * | 2004-08-23 | 2008-05-20 | Unilever Nv | composição, formador de creme e/ou clareador, composição de alimento, processo para a manufatura de uma composição e uso de uma composição |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2133508A1 (en) * | 1971-04-15 | 1972-12-01 | Inst Biochimie | 4-thiazolidinecarboxylic acid derivs - with in vivo thiol liberating activity |
| DE2607654A1 (de) * | 1975-03-05 | 1976-09-16 | Hoffmann La Roche | Vitaminierungsverfahren |
| FR2466459A1 (fr) * | 1979-10-05 | 1981-04-10 | Fabre Sa Pierre | Esters phenoxy isobutyriques d'hydroxy nicotinamides et leurs sels, leur procede de preparation et leur application en therapeutique |
| RO81579B1 (ro) * | 1981-01-20 | 1983-04-30 | Institutul De Cercetari Chimico-Farmaceutice | Granule cu efect hepatoprotector, hipocolesterolemiant si reconfortant general |
| ATE33333T1 (de) * | 1984-01-11 | 1988-04-15 | Von Mletzko Armin Dr | Diaetetikum. |
| JP2708633B2 (ja) | 1991-05-03 | 1998-02-04 | ライシオン テータート オサケユイチア アクティエボラーグ | 血清における高コレステロールレベルを低めるための物質及びその物質を調製するための方法 |
| FR2704556B1 (fr) * | 1993-04-30 | 1995-07-13 | Rhone Poulenc Rorer Sa | Virus recombinants et leur utilisation en thérapie génique. |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
-
1996
- 1996-11-07 CZ CZ963268A patent/CZ326896A3/cs unknown
-
1997
- 1997-10-30 EA EA199800624A patent/EA199800624A1/ru unknown
- 1997-10-30 SK SK930-98A patent/SK93098A3/sk unknown
- 1997-10-30 PL PL97327668A patent/PL327668A1/xx unknown
- 1997-10-30 EP EP97909116A patent/EP0918466A1/en not_active Withdrawn
- 1997-10-30 HU HU0001100A patent/HUP0001100A3/hu unknown
- 1997-10-30 WO PCT/CZ1997/000038 patent/WO1998019555A1/en not_active Application Discontinuation
- 1997-10-30 EE EE9800212A patent/EE9800212A/xx unknown
-
1998
- 1998-07-23 LT LT98-096A patent/LT4528B/lt not_active IP Right Cessation
- 1998-07-27 LV LVP-98-156A patent/LV12174B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT98096A (en) | 1999-02-25 |
| LV12174A (lv) | 1998-12-20 |
| EA199800624A1 (ru) | 1998-12-24 |
| LT4528B (lt) | 1999-07-26 |
| PL327668A1 (en) | 1998-12-21 |
| CZ326896A3 (cs) | 1998-05-13 |
| SK93098A3 (en) | 1999-01-11 |
| HUP0001100A3 (en) | 2001-02-28 |
| WO1998019555A1 (en) | 1998-05-14 |
| EE9800212A (et) | 1998-12-15 |
| EP0918466A1 (en) | 1999-06-02 |
| HUP0001100A2 (hu) | 2000-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ackman | Seafood lipids and fatty acids | |
| KR101331658B1 (ko) | 오메가-3 및 오메가-6 지방산을 함유하는 글리세로인지질 | |
| Ostlund Jr et al. | Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene | |
| DE69622722T2 (de) | Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms | |
| DE60210465T2 (de) | Verstärktes reiskleie-nahrungsmittelprodukt zur unterstützung der gesundheit von herz und kreislauf | |
| CA2519773C (en) | Lipid-improving agent and composition containing lipid-improving agent | |
| DE69630195T2 (de) | Verwendung eines ausgleichenden zusatzstoffes für omega-6 und omega-3 ungesättigte fettsäure | |
| AU2018389595B2 (en) | Lysophosphatidylcholine compositions | |
| US20020142089A1 (en) | Oil composition | |
| US10327452B2 (en) | Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid | |
| JP2003048831A (ja) | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 | |
| JP5697293B2 (ja) | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 | |
| JP2005528435A (ja) | ポリコサノール組成物、新規供給源からの抽出、およびその使用 | |
| EP1211305A1 (en) | Fat compositions | |
| BRPI0407338B8 (pt) | nutriente dietético ou suplemento alimentar compreendendo uma composição comestível, bem como uma composição farmacêutica oralmente administrável e respectivos usos | |
| Solomando et al. | Study on fish oil microcapsules as neat and added to meat model systems: Enrichment and bioaccesibility of EPA and DHA | |
| Solomando et al. | Lipid digestion and oxidative stability in ω-3-enriched meat model systems: Effect of fish oil microcapsules and processing or culinary cooking | |
| KR100548602B1 (ko) | 항콜레스테롤 식용 기름 | |
| JP3289165B2 (ja) | ドコサヘキサエン酸含有卵黄油の製造方法 | |
| LV12174B (en) | FATS WITH SPECIFIC ANTI-CELLULOTIC EFFECTS | |
| Golczewski et al. | Enhancement of maze learning in old C57BL/6 mice by dietary lecithin | |
| JP2004083902A (ja) | 油脂組成物 | |
| JP2016172770A (ja) | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 | |
| JPH01502345A (ja) | オイル組成物の調製方法 | |
| JP5496163B2 (ja) | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |